Changes, they are a comin’!
If only the title of this blog were a true indication of how I am feeling about the latest developments in Matthew’s case and with psychotropic medication prescribing in general.
Certainly we are making progress; if you can call a cautionary position statement being issued by the Canadian Pediatric Society, after having Health Canada warnings around for over half a decade progress. The position statement can be found here: http://www.cps.ca/english/statements/FN/fn11-02.htm
Experts in the fields of neo-natology and drug exposure during pregnancy have been advocating for over a decade that babies exposed to SSRI’s and SNRI’s must be monitored for adverse events at birth. Even the drug company shill Gideon Koren at the Motherisk Program in Toronto has gone on record as far back as 2008 saying that we should at least be monitoring babies exposed to antidepressant drugs. So, the position statement being issued by the Canadian Pediatric Society is best summed up in the words of our good friend and ally Barbara Mintzes from the Therapeutics Initiative at the University of British Columbia. She stated the following to me after reading it:
I just looked at the CPS position statement and agree that this is bad advice – essentially supports SSRI use in pregnancy. For paroxetine the only recommendation is lowering the dose or maybe switching antidepressants. All of the evidence on harm from SSRI use in pregnancy is treated with a heavy dose of doubt, concern about methods etc., but the benefits of antidepressants in pregnancy are taken at face value. I didn’t see any recommendation for first-line use of non-drug treatments in pregnancy, for example, and SSRIs are seen as necessary for ‘moderate to severe depression’ despite their poor record of effectiveness. There are no direct recommendations to avoid antidepressant use if possible, to look at other options.
I and most others not on a drug company payroll would tend to concur, Barbara. What the CPS position statement fails to mention is that each of the authors of said statement either have pharmaceutical company conflicts or are heavily influenced by those that do. You can look it up for yourself.
As it has been quite some time since I last blogged, we have had some very exciting developments happen as of late. Recently we have had a wonderful woman come in to our lives, Dr. Gerarda Cronin. She is the new Medical Director for Perinatal and Child Health for the Interior Health Authority of BC. Apparently, her job was created in the wake of Matthew’s death, and we are extremely grateful for her. In her capacity as the Regional Medical Director, Dr. Cronin also has a considerable amount of influence with not only Provincial Health standards, but also those at a national level as well.
This past week, Dr. Cronin forwarded to me the following edict from Perinatal Services BC. I take great pride knowing that it has been our hard work and diligence and the media pressure that has been continually applied by our good friends locally as well as at a national level by the CBC, that indeed is causing the necessary governmental bodies to act.
As the advisory states, we have been asked to be part of the Provincial working group that it alludes to. I guess these people understand that we won’t be silenced and that we in fact have some important things to say.
I have come to a stark realization this past week, that we in fact are treading on uncharted ground. If I am not mistaken, no jurisdiction in North America, perhaps even the world, has taken steps to formally address the dangers that psychotropic drugs pose to developing and newborn babies. If we are remembered for nothing else, and if Matthew is remembered for nothing else, his life was lost so that countless others may be saved. Although the pain can be unbearable at times, we know our angel is cheering us on. We will not be silenced, we will not give up.
Entry filed under: Canadian Pediatric Society, Congenital Heart Defect, coroner, Effexor, Infant Death, Infant loss, Interior Health Authority, mothers act, Patent Ductus Arteriosis, Pregnacy, psychiatry, SSRI, Transposition of the Great Arteries, Uncategorized.